PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
430.00
-4.00 (-0.92%)
At close: Nov 19, 2025

IDX:OBAT Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
142,433120,62756,93038,49637,853
Revenue Growth (YoY)
54.09%111.89%47.89%1.70%-
Cost of Revenue
77,25964,20634,57819,02214,872
Gross Profit
65,17556,42122,35219,47422,981
Selling, General & Admin
24,05918,5327,7515,7524,498
Other Operating Expenses
-1,316110.2694.21110.23188.84
Operating Expenses
22,74218,6437,8455,8624,687
Operating Income
42,43237,77814,50713,61118,294
Interest Expense
-946.6-1,381-1,253-845.28-279.34
Interest & Investment Income
2,6742,6741,8221,369750.66
Earnings From Equity Investments
410.57406.25-250.26--
Other Non Operating Income (Expenses)
-2,16852.54-1.45-2.611.74
EBT Excluding Unusual Items
42,40239,53114,82414,13318,767
Asset Writedown
-3.83-3.83-66.98-2.97-7.76
Other Unusual Items
--337.11816.75731.4
Pretax Income
42,39839,52715,09414,94619,491
Income Tax Expense
5,6319,0283,1863,3224,184
Earnings From Continuing Operations
36,76730,49911,90811,62515,307
Minority Interest in Earnings
-2,345-1,07365.94759.76342.69
Net Income
34,42229,42611,97412,38415,649
Net Income to Common
34,42229,42611,97412,38415,649
Net Income Growth
68.27%145.75%-3.32%-20.86%-
Shares Outstanding (Basic)
669600430463463
Shares Outstanding (Diluted)
669600430463463
Shares Change (YoY)
55.46%39.53%-7.13%--
EPS (Basic)
51.4949.0427.8526.7533.80
EPS (Diluted)
51.4949.0427.8526.7533.80
EPS Growth
8.24%76.12%4.10%-20.86%-
Free Cash Flow
-2,1386,3556,5287,14814,908
Free Cash Flow Per Share
-3.2010.5915.1815.4432.20
Dividend Per Share
22.37022.37016.95032.40017.280
Dividend Growth
31.98%31.98%-47.69%87.50%-
Gross Margin
45.76%46.77%39.26%50.59%60.71%
Operating Margin
29.79%31.32%25.48%35.36%48.33%
Profit Margin
24.17%24.39%21.03%32.17%41.34%
Free Cash Flow Margin
-1.50%5.27%11.47%18.57%39.38%
EBITDA
44,86339,97416,58214,87519,026
EBITDA Margin
31.50%33.14%29.13%38.64%50.26%
D&A For EBITDA
2,4312,1962,0751,263731.94
EBIT
42,43237,77814,50713,61118,294
EBIT Margin
29.79%31.32%25.48%35.36%48.33%
Effective Tax Rate
13.28%22.84%21.11%22.23%21.47%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.